Closing Bell: Knight Therapeutics Inc down on Thursday (GUD)

Knight Therapeutics Inc opened trading today at $5.70 and closed at $5.71. prices ranged from a low of $5.68 to a high of $5.76.

Share prices shrank -0.52% from the previous day's close of $5.74.

Today across North America, the TSX Composite closed -0.54% at 22726.76, the S&P 500 closed -1.39% at 5588.27, the Dow Jones Industrial Average closed 0.59% at 41198.08 and the Nasdaq Composite closed -2.77% at 17996.92.

Knight Therapeutics Inc traded under GUD on the Toronto Stock Exchange (TSX).

Trading volume was 56,069 on 306 total trades, while having an average volume of 41,068 over the last 5-days.

The TSX overall saw 1,017 price advancers against 4,222 declines and 91 unchanged.

During the prior 52 weeks, GUD.TO has traded as high as $6.22 (May 15,2024) and low as $4.35 (October 23,2023). Moreover, the shares have boosted 15.82% in the last 52 weeks, while they have advanced 10.02% year-to-date.

Following today's trading, Knight Therapeutics Inc has a market capitalization of $581.90 million on a float of 101,376 shares outstanding. Its annual EPS is $-0.16.

Knight Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Montreal, CAN.

Currently, Knight Therapeutics Inc has an average recommendation of "Moderate Buy" based on 4.00 analysts according to Zacks. Currently, there are 3 buy ratings and 1 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..